Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000673448 | SCV000798651 | likely pathogenic | Fanconi anemia complementation group C | 2018-03-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001868271 | SCV002201110 | pathogenic | Fanconi anemia | 2021-04-23 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser393Argfs*21) in the FANCC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCC are known to be pathogenic (PMID: 17924555). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with FANCC-related conditions. For these reasons, this variant has been classified as Pathogenic. |